The immune response that accompanies spinal cord injury contributes to both injury and reparative processes. It is this duality that is the focus of this review. Here, we consider the complex cellular and molecular immune responses that lead to the infiltration of leukocytes and glial activation, promote oxidative stress and tissue damage, influence wound healing, and subsequently modulate locomotor recovery. Immunomodulatory strategies to improve outcomes are gaining momentum as ongoing research carefully dissects those pathways which likely mediate cell injury from those which favor recovery processes. Current therapeutic strategies address divergent approaches including early immunoblockade and vaccination with immune cells to prevent early tissue damage and support a wound-healing environment that favors plasticity. Despite these advances, there remain basic questions regarding how inflammatory cells interact in the injured spinal cord. Such questions likely arise as a result of our limited understanding of immune cell/neural interactions in a dynamic environment that culminates in progressive cell injury, demyelination, and regenerative failure.
Introduction
Leukocytes are key responders to spinal cord injury. Their actions are immune-cell specific and driven by a dynamic environment where early cell injury, axonal degeneration, and demyelination become integrated into complex wound-healing events including angiogenesis and glial scar formation. In this review, we consider spinal cord injury in the context of innate and adaptive immunity and address the molecular mechanisms that govern leukocyte recruitment and activation as well as leukocyte-mediated cell injury and repair processes. Lastly, we consider the controversy of immunomodulation by vaccination with immune cells as a strategy for the treatment of spinal cord injury.
Immune privilege and the spinal cord
The central nervous system (CNS) has been considered immune privileged because of its inability to mount an immune response and process antigens [1] . However, we now know that the CNS, when challenged by injury and systemic infections, has the ability to mount a well-organized immune response [2] . Evidence over the past two decades has thus redefined the CNS from 'immunologically privileged' to an 'immunologically quiescent' site [3] . This quiescent state is dramatically altered in the injured spinal cord where there is an orchestrated invasion of circulating immune cells, activation of resident microglia and astrocytes, and expression of classic immune and inflammatory mediators including complement, cytokines, and chemokines [4] . 
